DarioHealth Corp. Revenue 2013–2025
DarioHealth Corp. annual/quarterly revenue history and growth rate from 2013 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- DarioHealth Corp. revenue for the quarter ending March 31, 2026 was 5.6 M, a 17.30% decrease year-over-year.
- DarioHealth Corp. revenue for the twelve months ending March 31, 2026 was 22.7 M, a 1.05% decrease year-over-year.
- DarioHealth Corp. annual revenue for 2025 was 22.4 M, a 17.31% decrease from 2024.
- DarioHealth Corp. annual revenue for 2024 was 27.0 M, a 32.86% increase from 2023.
- DarioHealth Corp. annual revenue for 2023 was 20.4 M, a 26.41% decrease from 2022.
- DarioHealth Corp. annual revenue for 2022 was 27.7 M.
DarioHealth Corp. (DRIO) — Frequently Asked Questions
DarioHealth Corp. (DRIO) is a publicly traded US company. It has a market capitalization of $29M. In fiscal 2025 it reported revenue of $22M and net income of -$42M. Explore DRIO's stock price, financial statements, earnings history, margins and key ratios below.
What is DarioHealth Corp.'s market cap?
DarioHealth Corp. (DRIO) has a market capitalization of $29M.
What is the DRIO stock price?
DRIO trades at $7.20 (-0.14% on the day).
How much revenue does DarioHealth Corp. make?
DarioHealth Corp. reported revenue of $22M in fiscal 2025.
Is DRIO profitable?
In fiscal 2025, DarioHealth Corp. reported net income of -$42M.
What is DRIO's P/E ratio?
Based on diluted EPS, DRIO has a price-to-earnings (P/E) ratio of about 0.7.